Skip to content

"Conquer Catharsis": Evaluation of a virtual reality-based biofeedback relaxation training program for children and adolescents

"Conquer Catharsis": Evaluation of a virtual reality-based biofeedback relaxation training program for children and adolescents - Conquer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033887
Enrollment
40
Registered
2024-03-13
Start date
2019-11-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32

Interventions

Group 1: virtual reality (VR) based biofeedback training: 10 weekly sessions of 50-60 min biofeedback training using the innovative VR-based biofeedback program "Conquer Catharsis", which is presented

Sponsors

Medizinische Universität Wien
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years

Inclusion criteria

Inclusion criteria: Patients with an existing primary somatic or mental illness are included in the study if they show pronounced concomitant symptoms of specific anxiety (e.g. performance anxiety, social anxiety) or mild or moderate comorbid depressive symptoms with problems in autonomic stress regulation.

Exclusion criteria

Exclusion criteria: The exclusion criteria include severe cognitive impairment (IQ<70), a lack of German language skills, a diagnosis of schizophrenia, schizotypal or delusional disorder (F20-29), bipolar affective disorder (F31) or a manic episode (F30). In addition, children and adolescents with a tendency to motion sickness (kinetosis) are also excluded, as this can be a hindrance to the VR environment via VR glasses.

Design outcomes

Primary

MeasureTime frame
Chronic stress: This is recorded at three points in time using the validated and standardized self-report questionnaire, the 10-item Perceived Stress Scale (PSS, Klein et al., 2016): before the training (T0), immediately after the last training session (T1) and at a 3-month-follow-up (T2), the participating children and adolescents are asked to complete the questionnaire.

Secondary

MeasureTime frame
clinical symptoms, ability to relax, health related quality of life, adherence, side effects (at all three points in time: T0, T1, T2)

Countries

Austria

Contacts

Public ContactAnna Felnhofer

Medizinische Universität Wien

anna.felnhofer@meduniwien.ac.at+4314040032720

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026